Anna Forbes, M.S.S.

Anna Forbes is a Washington, D.C.-based writer, organizer, and activist working in HIV/AIDS since 1985. Now an independent consultant focused on women's HIV-related needs and rights, her current and recent clients include a wide range of HIV-focused domestic and international NGOs and human rights initiatives.

Categories Covered:PrEP (HIV Pre-Exposure Prophylaxis), HIV Prevention and Transmission, Vaccines and Microbicides for HIV, Women, Living Well With HIV, Gay Men, Non-Medical HIV Prevention, Other Populations, HIV Stigma and Discrimination, HIV Advocacy and Activism, Tools and Tips for HIV Advocacy, HIV-Related Policy Issues, Disclosing Your HIV Status, HIV Drugs In Development

Latest by Anna Forbes, M.S.S.

Access Issues Dominate HIV Biomedical Prevention Summit

This 2017 Biomedical Prevention Conference in New Orleans focused less on the future of HIV prevention tools and more on issues preventing communities most in need from accessing PrEP.

By Anna Forbes, M.S.S.

Why Are HIV Groups Charging Gilead With Bad Behavior in New PrEP Trial?

"Gilead is not following the accepted standard for community engagement in its new pre-exposure prophylaxis (PrEP) trial," write Anna Forbes and Marc-André LeBlanc, explaining that concern is inspired, in part, by controversies in earlier PrEP trials...

By Anna Forbes, M.S.S. and Marc-André LeBlanc

Celebrating HIV Prevention Choices for Women and Receptive Sex Partners of All Genders

All of us deserve to have pleasurable, consensual, safe, satisfying sex shaped only by our imaginations, says Anna Forbes, as she celebrates the growing range of HIV prevention options.

By Anna Forbes, M.S.S.

'Female' Condoms Cost Too Much: A Call for HIV Prevention Equality for Receptive Sex Partners

Who can break the cycle of the high cost of the "female" condoms for HIV prevention in people of all genders who have receptive sex? It's the U.S. FDA, according to the National Female Condom Coalition.

By Jessica Terlikowski and Anna Forbes, M.S.S.

Building Solidarity to Overcome Invisibility: Sex Workers and HIV-Focused Activism

"Even as federal agencies and public health organizations have taken steps to address HIV in vulnerable populations, sex workers have been left out of the conversation," writes Anna Forbes.

By Anna Forbes, M.S.S. for Rewire

Stop the TPP from Putting HIV Treatment Out of Reach!

The Trans-Pacific Partnership (TPP) will make it easier for drug companies to demand longer patent extensions, limiting access to affordable, generic medicines used by millions worldwide.

By Anna Forbes, M.S.S. for HIV Prevention Justice Alliance

AIDS Healthcare Foundation's Demand for Medical Records Endangers Us All

In the atmosphere of HIV criminalization, demanding that HIV testing clinics release private records is appalling, according to advocate Anna Forbes. It is also a warning, she says, that people living with HIV, like people working in the sex industry...

By Anna Forbes, M.S.S.

Not So Fast: Why HIV Rates May Not Be Truly Dropping Among U.S. Women

Scrutinizing the reports of declining HIV rates in U.S. women, advocate Anna Forbes remains skeptical. With many women undiagnosed, she asks if a significant proportion of women living with HIV, including transgender women, are simply going uncounted...

By Anna Forbes, M.S.S.

Beyond the Media Hype for HIV Prevention Technology

At next month's International AIDS Conference, the media is likely to cover the heck out of "HIV treatment as prevention" stories. But Anna Forbes of the U.S. Positive Women's Network urges us all to look beyond those obvious headlines to some of the...

By Anna Forbes, M.S.S. for Positive Women's Network of the United States of America (PWN-USA)

Microbicides: When, How and Why Care Now?

If you are a regular reader of Positively Aware -- or if you just live in the same universe as Jim Pickett (a regular contributor to this magazine) -- you have undoubtedly heard of microbicides (m-KRO'-b-sdz).

Wouldn't it be great if there were so...

By Anna Forbes, M.S.S. for Positively Aware